Sarah James
Stock Analyst at Cantor Fitzgerald
(1.24)
# 3,560
Out of 4,944 analysts
284
Total ratings
29.44%
Success rate
-10.37%
Average return
Main Sectors:
Stocks Rated by Sarah James
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PGNY Progyny | Maintains: Overweight | $26 → $28 | $21.75 | +28.74% | 15 | Aug 8, 2025 | |
| HCAT Health Catalyst | Downgrades: Neutral | $9 → $4 | $3.00 | +33.33% | 7 | Aug 8, 2025 | |
| CNC Centene | Downgrades: Neutral | $65 → $38 | $26.17 | +45.20% | 14 | Jul 28, 2025 | |
| MOH Molina Healthcare | Downgrades: Neutral | $312 → $210 | $157.31 | +33.49% | 12 | Jul 25, 2025 | |
| HUM Humana | Reiterates: Neutral | $290 | $274.94 | +5.48% | 21 | May 1, 2025 | |
| ELV Elevance Health | Reiterates: Overweight | $485 | $292.48 | +65.82% | 20 | Apr 23, 2025 | |
| CI The Cigna Group | Maintains: Overweight | $350 → $365 | $280.47 | +30.14% | 21 | Mar 20, 2025 | |
| TBRG TruBridge | Maintains: Overweight | $20 → $29 | $19.70 | +47.21% | 6 | Mar 11, 2025 | |
| LFMD LifeMD | Reiterates: Overweight | $15 | $6.83 | +119.62% | 11 | Mar 11, 2025 | |
| THC Tenet Healthcare | Reiterates: Overweight | $177 | $170.48 | +3.82% | 20 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $405 | $390.31 | +3.76% | 19 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $700 | $261.57 | +167.61% | 17 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $52 | $20.33 | +155.78% | 13 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $219 | $175.21 | +24.99% | 24 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $43 | $22.98 | +87.12% | 12 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $62 | $65.51 | -5.36% | 14 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $5 | $1.66 | +201.20% | 8 | Sep 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $10 | $6.87 | +45.56% | 2 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $101 | $100.95 | +0.05% | 7 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $133 | $132.08 | +0.70% | 6 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $42 | $25.45 | +65.03% | 3 | Aug 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $6 → $5 | $3.62 | +38.12% | 2 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $5 | $7.24 | -30.94% | 2 | Aug 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $14 → $21 | $14.64 | +43.44% | 3 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $39 | $63.60 | -38.68% | 1 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $193 | $67.52 | +185.84% | 2 | Sep 15, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $2.56 | - | 2 | Mar 1, 2017 |
Progyny
Aug 8, 2025
Maintains: Overweight
Price Target: $26 → $28
Current: $21.75
Upside: +28.74%
Health Catalyst
Aug 8, 2025
Downgrades: Neutral
Price Target: $9 → $4
Current: $3.00
Upside: +33.33%
Centene
Jul 28, 2025
Downgrades: Neutral
Price Target: $65 → $38
Current: $26.17
Upside: +45.20%
Molina Healthcare
Jul 25, 2025
Downgrades: Neutral
Price Target: $312 → $210
Current: $157.31
Upside: +33.49%
Humana
May 1, 2025
Reiterates: Neutral
Price Target: $290
Current: $274.94
Upside: +5.48%
Elevance Health
Apr 23, 2025
Reiterates: Overweight
Price Target: $485
Current: $292.48
Upside: +65.82%
The Cigna Group
Mar 20, 2025
Maintains: Overweight
Price Target: $350 → $365
Current: $280.47
Upside: +30.14%
TruBridge
Mar 11, 2025
Maintains: Overweight
Price Target: $20 → $29
Current: $19.70
Upside: +47.21%
LifeMD
Mar 11, 2025
Reiterates: Overweight
Price Target: $15
Current: $6.83
Upside: +119.62%
Tenet Healthcare
Feb 13, 2025
Reiterates: Overweight
Price Target: $177
Current: $170.48
Upside: +3.82%
Jan 27, 2025
Reiterates: Overweight
Price Target: $405
Current: $390.31
Upside: +3.76%
Jan 17, 2025
Reiterates: Overweight
Price Target: $700
Current: $261.57
Upside: +167.61%
Dec 10, 2024
Reiterates: Neutral
Price Target: $52
Current: $20.33
Upside: +155.78%
Oct 25, 2024
Reiterates: Neutral
Price Target: $219
Current: $175.21
Upside: +24.99%
Oct 4, 2024
Reiterates: Overweight
Price Target: $43
Current: $22.98
Upside: +87.12%
Oct 1, 2024
Reiterates: Neutral
Price Target: $62
Current: $65.51
Upside: -5.36%
Sep 20, 2024
Reiterates: Overweight
Price Target: $5
Current: $1.66
Upside: +201.20%
Aug 20, 2024
Reiterates: Overweight
Price Target: $10
Current: $6.87
Upside: +45.56%
Jul 25, 2024
Reiterates: Neutral
Price Target: $101
Current: $100.95
Upside: +0.05%
Mar 6, 2024
Initiates: Equal-Weight
Price Target: $133
Current: $132.08
Upside: +0.70%
Aug 22, 2023
Reiterates: Overweight
Price Target: $42
Current: $25.45
Upside: +65.03%
Sep 15, 2022
Maintains: Equal-Weight
Price Target: $6 → $5
Current: $3.62
Upside: +38.12%
Aug 19, 2022
Maintains: Overweight
Price Target: $7 → $5
Current: $7.24
Upside: -30.94%
Aug 8, 2022
Maintains: Overweight
Price Target: $14 → $21
Current: $14.64
Upside: +43.44%
Aug 12, 2021
Initiates: Overweight
Price Target: $39
Current: $63.60
Upside: -38.68%
Sep 15, 2017
Upgrades: Overweight
Price Target: $193
Current: $67.52
Upside: +185.84%
Mar 1, 2017
Downgrades: Underweight
Price Target: n/a
Current: $2.56
Upside: -